Tuesday, February 28, 2017 03:20 AM


The price of EpiPens has surged in recent years an increase connected to the device, not the epinephrine, which is a hormone also known as adrenaline and costs pennies for a dose. A package of two EpiPens now costs more than $600[1], up from just over $100 in 2009. In response to public outcry and lawmaker scrutiny, Mylan last December released its own generic version[2] of the device at about half the cost, but thats still out of reach for many people.

Meanwhile, some insurers have dropped coverage of the pricey name-brand auto-injector pack or made sure customers have access to cost-effective alternatives, and the drugstore chain CVS reduced the price of a generic competitor. But all still cost at least $109.

Fixes like Dr. Londons can alleviate the pricing issue, but replicating this approach on a large scale could pose problems, since someone with medical expertise must do the refilling to avoid contaminating the device, meet quality standards for the device itself, and make the user aware ...

News source: The New York Times

See also: Steven Enrich